Compounds > 1-hexadecyl-2-acetyl-glycero-3-phosphocholine
Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and 2',5'-dihydroxychalcone

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with 2',5'-dihydroxychalcone in 1 studies

Compound Research Comparison

Studies
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Trials
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Recent Studies (post-2010)
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Studies
(2',5'-dihydroxychalcone)		Trials
(2',5'-dihydroxychalcone)		Recent Studies (post-2010) (2',5'-dihydroxychalcone)
9,156187552903

Protein Interaction Comparison

ProteinTaxonomy1-hexadecyl-2-acetyl-glycero-3-phosphocholine (IC50)2',5'-dihydroxychalcone (IC50)
Beta-glucuronidaseHomo sapiens (human)2.3

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hsu, MF; Ko, FN; Lee, TH; Lin, CN; Teng, CM; Wang, JP1

Other Studies

1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and 2',5'-dihydroxychalcone

ArticleYear
2',5'-Dihydroxychalcone as a potent chemical mediator and cyclooxygenase inhibitor.
    The Journal of pharmacy and pharmacology, 1997, Volume: 49, Issue:5

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arachidonic Acid; Chalcone; Chalcones; Cyclooxygenase Inhibitors; Indomethacin; N-Formylmethionine Leucyl-Phenylalanine; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors; Rabbits; Rats; Structure-Activity Relationship; Thrombin

1997